Evoq Remedies Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Evoq Remedies Ltd. on BSE

Load latest

Evoq Remedies Ltd.

22 Jan 2024

3.95

-4.82%

Board Meeting

Evoq Remedies Ltd - 543500 - Board Meeting Outcome for Outcome Of Board Meeting Held Today …

BSE India

Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 22nd January, 2024 at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola Ahmedabad, Gujarat, India, 380 060 which commenced at 2:00 P.M. and concluded at 3:00 P.M. interalia has, considered and approved as per attachment.

pdf

Evoq Remedies Ltd.

16 Jan 2024

3.95

-4.82%

Board Meeting

Evoq Remedies Ltd - 543500 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 ,inter alia, to consider and approve and discuss proposal of raising of funds by way of issue of Equity shares on preferential allotment basis for cash consideration, subject to the receipt of necessary approvals. Further, pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, we hereby inform you that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Tuesday, 16th January, 2024 till 48 hours after the conclusion of the meeting.

pdf

Evoq Remedies Ltd.

12 Jan 2024

3.95

-4.82%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel

pdf

Evoq Remedies Ltd.

12 Jan 2024

3.95

-4.82%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhumishth Narendrabhai Patel

pdf

Evoq Remedies Ltd.

12 Jan 2024

3.95

-4.82%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Bhumishth Patel

pdf

Evoq Remedies Ltd.

12 Jan 2024

3.95

-4.82%

SAST

Evoq Remedies Ltd - 543500 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Payal Bhumishth Patel

pdf

Evoq Remedies Ltd.

10 Jan 2024

3.95

-4.82%

Company Update

Evoq Remedies Ltd - 543500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Submission of certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st December, 2023

pdf

Evoq Remedies Ltd.

10 Jan 2024

3.95

-4.82%

Company Update

Evoq Remedies Ltd - 543500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015 - Export Order of Rs. 136 Crores as per attachment.

pdf

Evoq Remedies Ltd.

05 Jan 2024

3.95

-4.82%

Company Update

Evoq Remedies Ltd - 543500 - Clarification Sought On Significant Movement In Price

BSE India

Clarification regarding significant movement in price as per attachment.

pdf

Evoq Remedies Ltd.

01 Jan 2024

3.95

-4.82%

Company Update

Evoq Remedies Ltd - 543500 - Clarification sought from Evoq Remedies Ltd

BSE India

The Exchange has sought clarification from Evoq Remedies Ltd on January 1, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

VOTE: Is Evoq Remedies Ltd. worth buying?

12 Votes:

Buy 91.67%

Sell 8.33%